Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 311 to 320 of 1295
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK ManA 37071 Insp GMP 37071/16232434-0013[V] GMPC

PIRAMAL CRITICAL CARE LIMITED, SUITE 4, GROUND FLOOR, HEATHROW BOULEVARD, EAST WING, 280 BATH ROAD, WEST DRAYTON, UB7 0DQ, UNITED KINGDOM

UNITED KINGDOM
UK MIA 37071 Insp GMP 37071/16232434-0012[H] GMPC

PIRAMAL CRITICAL CARE LIMITED, SUITE 4, GROUND FLOOR, HEATHROW BOULEVARD, EAST WING, 280 BATH ROAD, WEST DRAYTON, UB7 0DQ, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 57761 Insp IMP 57761/32404750-0003[I] GMPC

QMED CLINICAL SERVICES, UNIT 4, THORNHAM GROVE, LONDON, E15 1DN, UNITED KINGDOM

UNITED KINGDOM
UK GMP 43637 Insp GMP/IMP 43637/18603487-0003 [H] GMPC

ARC PHARMA (UK) LIMITED , UNIT 3, CURO PARK, FROGMORE, ST. ALBANS, AL2 2DD, UNITED KINGDOM

UNITED KINGDOM
UK GMP 43637 Insp GMP/IMP 43637/18603487-0003 [V] GMPC

ARC PHARMA (UK) LIMITED , UNIT 3, CURO PARK, FROGMORE, ST. ALBANS, AL2 2DD, UNITED KINGDOM

UNITED KINGDOM
UK MIA 47991 Insp GMP 47991/16642630-0006[H] GMPC

SEQIRUS UK LIMITED, THE POINT, 29 MARKET STREET, MAIDENHEAD, SL6 8AA, UNITED KINGDOM

UNITED KINGDOM
UK MIA(IMP) 18532 Insp GMP/IMP 18532/29956-0052[I] GMPC

SEQIRUS VACCINES LIMITED , GASKILL ROAD, SPEKE, LIVERPOOL, L24 9GR, UNITED KINGDOM

UNITED KINGDOM
UK MIA 18532 Insp GMP/IMP 18532/29956-0052[H] GMPC

SEQIRUS VACCINES LIMITED , GASKILL ROAD, SPEKE, LIVERPOOL, L24 9GR, UNITED KINGDOM

UNITED KINGDOM
UK MIA 22920 Insp GMP 22920/37420058-0002[H] GMPC

MORNINGSIDE PHARMACEUTICALS LIMITED, SECOND FLOOR, BOSS COURT, 7 BARTON CLOSE, GROVE PARK, LEICESTER, LE19 1SJ, UNITED KINGDOM

UNITED KINGDOM
UK MIA 35533 Insp GMP 35533/37420056-0002[H] GMPC

ASPIRE PHARMA LIMITED, SECOND FLOOR, BOSS COURT, 7 BARTON CLOSE, GROVE PARK, LEICESTER, LE19 1SJ, UNITED KINGDOM

UNITED KINGDOM

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX